QA: Endocyte INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001235007_2018_Endocyte_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001235007, Endocyte INC

  xvar xval
0 AssetsCurrent 98,572,803
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,182,399
3 remainder_Assets 7,067
4 LiabilitiesCurrent 4,546,180
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 731,944
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,014,514
9 ResearchAndDevelopmentExpense 41,016,838
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,497,760
13 remainder_ComprehensiveNetIncome -2,549
  yvar yval
0 Assets 100,762,269
1 Liabilities 5,278,124
2 Expenses 55,031,352
3 Revenues 0
4 StockholdersEquity 95,484,145
5 NetIncome -53,533,592
6 ComprehensiveNetIncome -53,534,866
7 BaseVar 81,286,027
8 EconomicCapitalRatiobeforeLimitedLiability 2.92
9 EconomicCapitalRatio 3.63

Edgar->Model Mapping

Feature Distribution

Change over Time